
We run cohorts in London twice a year, with between 50 and 100 prospective founders taking part.
Our London companies include Tractable who recently raised a US$60M Series D round, and accuRx, who played a critical role in the UK’s vaccine roll-out.
We’ve seen several successful exits from our London cohorts, including Magic Pony Technology who were acquired for a reported US$150M.